60429-385 : Isradipine 2.5 mg Oral Capsule


NDC60429-385
Labeler: Golden State Medical Supply, Inc.
Product Type: Human Prescription Drug
Drug Name:  Isradipine
Dosage Form: Oral Capsule
Application #: ANDA077169
Rev. Date: 


Appearance:


Markings: A263
Shapes:  Capsule
Colors:  White
Size (mm): 16
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 60429-385-01: 100 CAPSULE IN 1 BOTTLE (60429‑385‑01)

Active Ingredients:

  • Isradipine

Dosage Strength:

  • 2.5 mg

Inactive Ingredients:

  • Starch, Corn
  • Silicon Dioxide
  • Gelatin
  • Lactose Monohydrate
  • Cellulose, Microcrystalline
  • Polyethylene Glycol 8000
  • Sodium Lauryl Sulfate
  • Titanium Dioxide
  • Ferrosoferric Oxide
  • D&c Yellow No. 10
  • Fd&c Blue No. 1
  • Fd&c Blue No. 2
  • Fd&c Red No. 40
  • Butyl Alcohol
  • Propylene Glycol
  • Shellac

Pharmaceutical Classes:

  • Calcium Channel Antagonists [MoA]
  • Dihydropyridine Calcium Channel Blocker [EPC]
  • Dihydropyridines [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 60429-386 Isradipine 5 mg Oral Capsule by Golden State Medical Supply, Inc.
  • 16252-539 Isradipine 2.5 mg Oral Capsule by Cobalt Laboratories
  • 16252-540 Isradipine 5 mg Oral Capsule by Cobalt Laboratories
  • 42806-263 Isradipine 2.5 mg Oral Capsule by Epic Pharma, LLC
  • 42806-264 Isradipine 5 mg Oral Capsule by Epic Pharma, LLC
  • 50268-454 Isradipine 2.5 mg/1 Oral Capsule by Avpak
  • 50268-455 Isradipine 5 mg/1 Oral Capsule by Avpak
  • 68151-1333 Isradipine 5 mg Oral Capsule by Carilion Materials Management
  • 68462-807 Isradipine 2.5 mg Oral Capsule by Glenmark Pharmaceuticals Inc., USA
  • 68462-808 Isradipine 5 mg Oral Capsule by Glenmark Pharmaceuticals Inc., USA

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 60429-385 QR Code

< Prev: 60429-384Next: 60429-386 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 January 2017.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA